For ideas or additional genes for the list, please email me:
Back to the Waldman Group Home Page
View the entire file sorted alphabetically
| LOCUS | GENE | ADDITIONAL NAMES |
|---|---|---|
| 1p13.2; | NRAS | ONCOGENE NRAS, NRAS1 |
| 1p13.3 | GSTM1 | GLUTATHIONE S-TRANSFERASE, MU-1 |
| 1p13.3 | RAP1A | RAS-RELATED PROTEIN 1A, KREV1 |
| 1p21-p13 | ARH9 | APLYSIA RAS-RELATED HOMOLOG 9 |
| 1p31-p22 | IGFBP10 | INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN; CYTESINE-RICH PROTEIN 61, MOUSE, HOMOLOG OF; CYR61 |
| 1p32 | EPS15 | EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE-15; ALL1 FUSED GENE FROM CHROMOSOME 1; AF1P |
| 1p32-q12 | M1S1 | MEMBRANE COMPONENT, CHROMOSOME 1, SURFACE MARKER 1 |
| 1p32 | BLYM | ONCOGENE BLYM: CHICKEN BURSAL LYMPHOMA |
| 1p32 | JUN | V-JUN AVIAN SARCOMA VIRUS 17 ONCOGENE HOMOLOG |
| 1p32 | RLF | RLF PROTEIN INVOLVED IN ACTIVATION OF LMYC |
| 1p33-p32 | TGFBR3 | TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE III |
| 1p34-p12 | DDIT1 | DNA DAMAGE-INDUCIBLE TRANSCRIPT 1; GADD45 |
| 1p34-p33 | TIE1 | TYROSINE KINASE WITH IMMUNOGLOBULIN AND EGF FACTOR HOMOLOGY DOMAINS TIE, PROTEIN RECEPTOR TYROSINE KINASE TIE-1 |
| 1p34.3 | MYCL1 | AVIAN MYELOCYTOMATOSIS ONC. HOMOLOG 1, LUNG CANCER DERIVED |
| 1p34 | MPL | MYELOPROLIFERATIVE LEUKEMIA VIRUS ONCOGENE |
| 1p35-p34.3 | LCK | LYMPHOCYTE-SPECIFIC PROTEIN TYROSINE KINASE |
| 1p35 | EBVS1 | EPSTEIN-BARR VIRUS INTEGRATION SITE; EPSTEIN-BARR VIRUS INSERTION SITE-1 |
| 1p35 | PLA2G2A | PHOSPHOLIPASE A2, GROUP IIA |
| 1p36.1-p35 | RAP1GA1 | RAP1, GTPase-ACTIVATING PROTEIN 1 |
| 1p36.2 | FGR | GARDNER RASHEED FELINE SARCOMA VIRUS ONCOGENE |
| 1p36.3-p36.2 | TNFR2 | TUMOR NECROSIS FACTOR RECEPTOR 2 |
| 1p36.3; | NB | NEUROBLASTOMA SUPPRESSOR |
| 1p36.3 | HKR3 | GLI-KRUPPEL FAMILY MEMBER HKR3 |
| 1p36 | BRCD2 | BREAST CANCER, DUCTAL, 2, BRCD2 |
| 1p36 | CDC2L1 | PK58, PROTEIN KINASE p58, CDC-RELATED PROTEIN KINASE p58, CELL DIVISION CYCLE 2-LIKE 1 |
| 1p36 | E2F2 | E2F TRANSCRIPTION FACTOR 2 |
| 1p36 | MLM | MALIGNANT MELANOMA; DYSPLASTIC NEVUS SYNDROME, HEREDITARY |
| 1p36 | RIZ | RETINOBLASTOMA BINDING ZN FINGER PROTEIN |
| 1pter-p22.1 | MTS1 | MALIGNANT TRANSFORMATION SUPPRESSION |
| 1pter-p22.1 | MTS1 | MALIGNANT TRANSFORMATION SUPPRESSION-1 |
| 1pter-p36 | ERPL1 | ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-1 |
| 1q21-q22 | NTRK1 | NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 1 |
| 1q21-q23 | PE1 | ONCOGENE PE-1, ETV3 |
| 1q21 | MUC1 | MUCIN 1, URINARY MUC1 PEANUT-REACTIVE URINARY MUCIN PUM MUCIN, TUMOR-ASSOCIATED EPITHELIAL POLYMORPHIC EPITHELIAL MUCIN PEM |
| 1q21 | PRCC | PAPILLARY RENAL CELL CARCINOMA; RCCP1 |
| 1q22-q24 | SKI | V-SKI AVIAN SARCOMA VIRAL ONCOGENE HOMOLOG |
| 1q23-q24 | TRK | TRK ONCOGENE |
| 1q24-q25 | ABL2 | V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 2 |
| 1q24-q25 | HPC1 | HEREDITARY PROSTATE CANCER 1 |
| 1q25 | TPR | TRANSLOCATED PROMOTER REGION |
| 1q31-32 | PDGFA | PCTAIRE PROTEIN KINASE 3 |
| 1q31-q32 | PCTK3 | PCTAIRE PROTEIN KINASE 3 |
| 1q32 | ELK4 | SRF ACCESSORY PROTEIN 1, SAP1, ETS-DOMAIN PROTEIN, ELK4 |
| 1q32 | ESX | ETS DOMAIN TRANSCRIPTION FACTOR, SERINE BOX |
| 1q32 | RBBP5 | RETINOBLASTOMA BINDING PROTEIN |
| 1q41 | TGFB2 | TRANSFORMING GROWTH FACTOR, BETA-2 |
| 1q42.2-q43 | HPC2 | HEREDITARY PROSTATE CANCER 2 |
| 2cen-q13 | RALB | V-RAL SIMIAN LEUKEMIA VIRAL ONCOGENE HOMOLOG B |
| 2p12 | PAP | PANCREATITIS-ASSOCIATED PROTEIN |
| 2p13 | MAD | MAD PROTEIN, MAX-BINDING PROTEIN |
| 2p13 | REL | AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG |
| 2p13 | TGFA | TRANSFORMING GROWTH FACTOR, ALPHA |
| 2p14-p13.4 | RAB1 | MEMBER RAS ONCOGENE FAMILY, RAB1 |
| 2p15-cen | CDK7 | CYCLIN-DEPENDENT KINASE7; CELL DIVISION PROTEIN PROTEIN KINASE 7; SERINE/THREONINE PROTEIN KINASE 1; STK1 |
| 2p16 | GTBP | G/T MISMATCH BINDING PROTEIN; MSH6 |
| 2p22-p21 | FCC1 | FAMILIAL COLON CANCER, NONPOLYPOSIS TYPE 1, COCA1, HNPCC, MSH2, mutS, |
| 2p24.1 | MYCN | AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE, NEUROBLASTOMA |
| 2pter-p12 | ARH6 | APLYSIA RAS-RELATED HOMOLOG 6 |
| 2q12-q14 | BUB1 | BUDDING UNINHIBITED BY BENZIMIDAZOLES 1 |
| 2q14-q21 | HS1 | ONCOGENE HIS1 |
| 2q14-q21 | LCO | LIVER CANCER ONCOGENE; ONCOGENE LCA |
| 2q14 | GLI2 | GLI-KRUPPEL FAMILY MEMBER 2 |
| 2q31-q33 | PMS1 | POSTMEITIC SEGREGATION INCREASED (S. CEREVISIAE) 1 |
| 2q33-q34 | IGFBP2 | INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2; IBP2; IGF-BP53 |
| 2q33-q36 | IGFBP5 | INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 5; IBP5 |
| 2q33-q36 | INHA | INHIBIN, ALPHA |
| 2q33.3-q34 | ERBB4 | V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG4, ONCOGENE ERBB4, TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER4 |
| 2q33 | PLCE | PHOSPHOLIPASE C, EPSILON |
| 3p11.2 | ETK1 | RECEPTOR TYROSINE KINASE HEK, HEK LYMPHOID RECEPTOR TYROSINE TYROSINE KINASE 1 ETK, EPH-LIKE |
| 3p14.2 | FHIT | FRAGILE HISTIDINE TRIAD GENE, FHIT |
| 3p14.2 | PTPRG | PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR TYPE, GAMMA; PROTEIN-TYROSINE PHOSPHATASE GAMA; PTPG |
| 3p14.2 | RCA1 | RENAL CARCINOMA, FAMILIAL, ASSOCIATED 1, HYPERNEPHROMA, RCC1, HRCA1 |
| 3p21-p14 | WNT5A | WINGLESS-TYPE MMTV INTEGRATION SITE-5A, HUMAN HOMOLOG |
| 3p21.1 | ARP | ARGININE-RICH PROTEIN |
| 3p21.3 | ARHA | RAS HOMOLOG GENE FAMILY, MEMBER A |
| 3p21.3 | FCC2 | FAMILIAL COLON CANCER, NONPOLYPOSIS TYPE 2, COCA2, HNPCC2 |
| 3p21.3 | SEMA3F | SEMAPHORIN III/F |
| 3p21.3 | SKMc15 | INTERFERON-RELATED PROTEIN |
| 3p21 | APH | ACYLPEPTIDE HYDROLASE |
| 3p21 | CDC25A | CELL DIVISION CYCLE 25A |
| 3p21 | MST1 | MACROPHAGE STIMULATING 1; HEPATOCYTE GROWTH FACTOR-LIKE PROTEIN; HGFL MACROPHAGE STIMULATING PROTEIN; MSP |
| 3p21 | UBE2 | UBIQUITIN-ACTIVATING ENZYME 2 |
| 3p22-p21.3 | CTNNB1 | CATENIN, BETA-1 |
| 3p22-p21 | ZNF35 | ZINC FINGER PROTEIN |
| 3p22 | TGFBR2 | TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE II |
| 3p23-p21 | SCCL | SMALL-CELL CANCER OF THE LUNG, SCLC1 |
| 3p23-p21 | TDGF1 | TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; CRIPTO GROWTH FACTOR; CRGF |
| 3p24 | RARB | RETINOIC ACID RECEPTOR, BETA |
| 3p25.1 | RAD23B | RAD23, YEAST, HUMAN HOMOLOG OF, B, HHR23B |
| 3p25 | RAF1 | V-RAF-1 MURINE LEUKEMIA V. ONCOGENE HOMOLOG 1 |
| 3p26 | VHL | VON HIPPEL-LINDAU SYNDROME |
| 3p32-p21 | TDGF1 | TERATOCARCINOMA-DERIVED GROWTH FACTOR 1, TDGF1, CRIPTO GROWTH FACTOR CRGF |
| 3p | FTC | THYROID CARCINOMA, FOLLICULAR |
| 3p | TOP2B | TOPOISOMERASE (DNA) II, BETA |
| 3q21 | CDCL1 | CELL DIVISION CYCLE LIKE 1 |
| 3q26.1-q26.2 | ECT2 | EPITHELIAL CELL TRANSFORMING SEQUENCE 2 ONCOGENE |
| 3q26 | EVI1 | ECOTROPIC VIRAL INTEGRATION SITE-1 |
| 3q26 | MDS1 | MYELODYSPLASIA SYNDROME 1, MYELODYSPLASIA SYNDROME-ASSOCIATED SEQUENCE-1 |
| 3q27 | BCL6 | B-CELL LYMPHOMA-6, BCL6 |
| 3q27 | EIF4G | EUKARYOTIC TRANSLATION INITIATION FACTOR 4G; EIF-4-GAMMA |
| 3q28 | FGF12 | FIBROBLAST GROWTH FACTOR 12; FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTOR-1; FHF1 |
| 4p16.3 | FGFR3 | FIBROBLAST GROWTH FACTOR RECEPTOR-3 |
| 4p16.3 | SH3BP2 | SH3 DOMAIN-BINDING PROTEIN 2 |
| 4p16 | GAK | CYCLIN G-ASSOCIATED KINASE |
| 4q12-q13 | GRO1 | GRO1 ONCOGENE |
| 4q12-q13 | GRO2 | GRO2 ONCOGENE |
| 4q12-q13 | GRO3 | GRO3 ONCOGENE |
| 4q12 | IGFBP7 | INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7; MAC25 |
| 4q12 | KDR | KINASE INSERT DOMAIN RECEPTOR; TYROSINE KINASE GROWTH FACTOR RECEPTOR; FLK-1 RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH FACTOR; FLK1; VEGF RECEPTOR; VEGFR |
| 4q12 | KIT | V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG KIT ONCOGENE MAST/STEM CELL GROWTH FACTOR RECEPTOR |
| 4q12 | PDGFRA | PDGFR2, PDGF RECEPTOR ALPHA |
| 4q13-q21 | AREG | AMPHIREGULIN; SCHWANNOMA-DERIVED GROWTH FACTOR; SDGF |
| 4q21-q25 | RAP1GDS1 | RAP1 (smg) GTPase-GDP DISSOCIATION STIMULATOR 1 |
| 4q21 | FGF5 | ONCOGENE FIBROBLAST GROWTH FACTOR-5 |
| 4q21 | INP10 | INTERFERON, GAMMA-INDUCED CELL LINE, PROTEIN 10 |
| 4q25-q27 | FGF2 | FIBROBLAST GROWTH FACTOR-2, FGF2, FIBROBLAST GROWTH FACTOR BASIC FGFB |
| 4q25 | EGF | EPIDERMAL GROWTH FACTOR |
| 4q26-q27 | IL2 | INTERLEUKIN 2; T-CELL GROWTH FACTOR; TCGF |
| 4q27 | CCNA | CYCLIN A |
| 4q28-q31 | TYS | SCLEROTYLOSIS |
| 4q32.1 | HCC2 | HEPATOCELLULAR CARCINOMA 2 |
| 5 | TFCOUP1 | TRAN SCRIPTION FACTOR COUP 1, CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 1 COUP-TF I ERBA-RELATED GENE-3 ERBAL3, EAR3 |
| 5p13 | DOC2 | DIFFERENTIALLY EXPRESSED IN OVARIAN CANCER-2 |
| 5p13 | SKP2 | S-PHASE KINASE-ASSOCIATED PROTEIN 2, CDK2/CYCLIN A-ASSOCIATED PROTEIN p45 |
| 5q11-q12 | MSH3 | MutS, E. COLI, HOMOLOG OF, 3 |
| 5q12 | CCNB1 | CYCLIN B |
| 5q13.3-q14 | CCNH | CYCLIN H; CDK-ACTIVATING KINASE; CYCLIN-DEPENDENT KINASE-ACTIVATING KINASE; CAK |
| 5q13.3 | RASA1 | RAS p21 PROTEIN ACTIVATOR 1, GUANOSINE TRIPHOSPHATASE-ACTIVATING PROTEIN GTPase-ACTIVATING PROTEIN GAP |
| 5q21 | APC | ADENOMATOUS POLYPOSIS OF THE COLON |
| 5q21 | MCC | MUTATED IN COLORECTAL CANCERS |
| 5q31 | TGFBI | TRANSFORMING GROWTH FACTOR, BETA-INDUCED, 68-KD; BETA-IG-H3; BIGH3 KERATOEPITHELIN |
| 5q31-q32 | PDGFRB | PLATELET-DERIVED GROWTH FACTOR RECEPTOR, BETA, PDGFRB, PDGFR |
| 5q31.1 | IL9 | INTERLEUKIN 9; T-CELL/MAST CELL GROWTH FACTOR P40 |
| 5q311 | CDC25 | MITOSIS INDUCER CDC25 |
| 5q31 | CDC25C | |
| 5q31 | CTNNA1 | CATENIN, ALPHA-1 |
| 5q31 | FGF1 | FIBROBLAST GROWTH FACTOR-1, FGF1, ENDOTHELIAL CELL GROWTH FACTOR ECGF FIBROBLAST GROWTH FACTOR, ACIDIC, FGFA, ECGFA, ECGFB, HEPARIN-BINDING GROWTH FACTOR-1 HBGF1 |
| 5q32-q34 | CCNG | CYCLIN G |
| 5q33.2-q33.3 | CSF1R | COLONY-STIMULATING FACTOR 1 RECEPTOR |
| 5q35.1-qter | FGFR4 | FIBROBLAST GROWTH FACTOR RECEPTOR 4 |
| 5q | RCC3 | RENAL CELL CARCINOMA 3 |
| 6 | IGFALS | INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN, ACID-LABILE SUBUNIT; IGFBP, SOLUBLE |
| 6p12 | VEGF | VASCULAR ENDOTHELIAL GROWTH FACTOR, VEGFA |
| 6p21.1-p12.2 | PTK7 | PROTEIN TYROSINE KINASE PTK7 |
| 6p21.2 | CDKN1A | CYCLIN-DEPENDENT INHIBITOR 1A, CDK-INTERACTING PROTEIN1 CIP1, WAF1, P21 |
| 6p21.2 | PIM | ONCOGENE PIM-1 |
| 6p21.3 | HFE | HEMOCHROMATOSIS; HH |
| 6p21.3 | LTA | LYMPHOTOXIN A, LYMPHOTOXIN-ALPHA TUMOR NECROSIS FACTOR, TNFB TNF, LYMPHOCYTE-DERIVED |
| 6p21.3 | NEP | NEUROEPITHELIAL TYROSINE KINASE; RECEPTOR TYROSINE KINASE NEP |
| 6p21.3 | TAP1 | TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX, 1 |
| 6p21.3 | TNFA | TUMOR NECROSIS FACTOR, TNF, TUMOR NECROSIS FACTOR, ALPHA CACHECTIN TNF, MONOCYTE-DERIVED TNF, MACROPHAGE-DERIVED |
| 6p21 | CCND3 | CYCLIN D3 |
| 6p22 | E2F3 | E2F TRANSCRIPTION FACTOR 3 |
| 6p25-p23 | IRF4 | INTERFERON REGULATORY FACTOR-4 |
| 6p25 | RREB1 | RAS-RESPONSIVE ELEMENT BINDING PROTEIN 1 |
| 6p | BAK1 | BCL2 ANTAGONIST KILLER 1; BCL-2 HOMOLOG BAK |
| 6q21 | CCNC | CYCLIN C |
| 6q21 | FYN | FYN ONCOGENE RELATED TO SRC, FGR, YES |
| 6q22 | MYB | V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG |
| 6q22 | ROS1 | ONCOGENE ROS |
| 6q23.1 | CTGF | CONNECTIVE TISSUE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 8; IGFBP8 |
| 6q23.3-q24 | MYB | MYB ONCOGENE |
| 6q24-q27 | MAS1 | MAS1 ONCOGENE |
| 6q25.3 | IGF2R | INSULIN GROWTH FACTOR TYPE 2 RECEPTOR |
| 6q25 | ESR1 | ESTROGEN RECEPTOR 1 |
| 6q26-q27 | ST8 | SUPPRESSION OF TUMORIGENICITY 8, OVARIAN TUMOR |
| 6q26 | IGF2R | INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR |
| 6q27 | MLLT4 | MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO , 4 |
| 6q | HMPS | POLYPOSIS SYNDROME, MIXED, HEREDITARY |
| 7 | YUASA | ONCOGENE YUASA |
| 7p11-12 | EGFR | EPIDERMAL GROWTH FACTOR RECEPTOR |
| 7p11.4-cen | ARAF2 | V-RAF MURINE SARCOMA 3611 VIRAL ONCOGENE HOMOLOG 2, ONCOGENE ARAF2 ONCOGENE PKS1 RAFA2 |
| 7p13 | GLI3 | ONCOGENE GLI3 |
| 7p14-p12 | IGFBP3 | INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3; IBP3 |
| 7p14-p12 | IGFBP1 | INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1; IBP1;PLACENTAL PROTEIN 12; IGF-BP25 |
| 7p15 | MYCLK1 | V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG-LIKE 1 |
| 7p22-p15 | RALA | V-RAL SIMIAN LEUKEMIA VIRAL ONCOGENE HOMOLOG A, , RAS-LIKE PROTEIN RAL |
| 7p22 | ETV1 | ETS VARIANT GENE 1 |
| 7p22 | PMS2 | POSTMEITIC SEGREGATION INCREASED (S. CEREVISIAE) 2 |
| 7q11.2 | SKP1A | S-PHASE KINASE-ASSOCIATED PROTEIN 1A, SKP1 CDK2/CYCLIN A-ASSOCIATED PROTEIN p19A |
| 7q21.1 | HGF | HEPATOCYTE GROWTH FACTOR; SCATTER FACTOR; SF; LUNG FIBROBLAST-DERIVED MITOGEN; HEPATOPOIETIN A |
| 7q21.1 | PGY1 | P-GLYCOPROTEIN-1, MULTIDRUG RESISTANCE MDR1 GP170 DOXORUBICIN RESISTANCE |
| 7q21.1 | PGY3 | P-GLYCOPROTEIN-3, MULTIDRUG RESISTANCE MDR3 |
| 7q21.1 | SRI | SORCIN, MULTIDRUG-RESISTANCE COMPLEX, CLASS 4 MDR COMPLEX, CLASS 4 |
| 7q21.3 | CALCR | CALCINTONIN RECEPTOR; CTR; CTR1 |
| 7q21 | EPO | ERYTHROPOIETIN; EP |
| 7q22 | VGF | VGF, NERVE GROWTH FACTOR-INDUCIBLE |
| 7q31 | IRP | INT1-RELATED PROTEIN, INT1L1, WINGLESS-TYPE MMTV INTEGRATION SITE-2 WNT2 |
| 7q31 | MET | MET PROTO-ONCOGENE |
| 7q32-q36 | EPHA1 | EPHRIN RECEPTOR EphA1 |
| 7q33 | PTN | PLEIOTROPHIN; NEURITE OUTGROWTH-PROMOTING FACTOR, HEPARIN BINDING; NEURITE GROWTH-PROMOTING FACTOR 1; NEGF1; HBGF8 |
| 7q34 | BRAF | V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1 |
| 7q36 | CDK5 | CYCLIN DEPENDENT KINASE 5 |
| 8p11.2-p11.1 | FGFR1 | FIBROBLAST GROWTH FACTOR RECEPTOR-1, FGFR1, FMS-LIKE TYROSINE KINASE-2 FLT2 FMS-LIKE GENE FLG |
| 8p21 | NKX3A | HOMEO BOX 3A, NK |
| 8p23.1-p21.3 | AAC1 | ARYLAMIDE ACETYLASE 1 |
| 8p23.1-p21.3 | NAT2 | ARYLAMINE N-ACETYLTRANSFERASE 2; ISONIAZID INACTIVATION |
| 8q11 | MOS | TRANSFORMATION GENE: ONCOGENE MOS |
| 8q13-qter | LYN | V-YES-1 YAMAGUCHI SARCOMA VIRAL RELATED ONCOGENE HOMOLOG |
| 8q21 | CKS1 | CDC2-ASSOCIATED PROTEIN CKS1, CDC28 |
| 8q22 | CBFA2T1 | CORE-BINDING FACTOR, ALPHA SUBUNIT 2, TRANSLOCATED TO, 1; ETO |
| 8q22 | MYBL1 | V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG-LIKE 1 |
| 8q24.12 | MYC | TRANSFORMATION GENE: ONCOGENE |
| 8q24.1 | NOV | NEPHROBLASTOMA OVEREXPRESSED GENE |
| 8q24.2 | PSCA | PROSTATE STEM CELL ANTIGEN |
| 8q24.3 | GLI4 | GLI-KRUPPEL FAMILY MEMBER GLI4 |
| 8q24.3 | GML | GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED MOLECULE-LIKE PROTEIN |
| 8q24 | PVT1 | ONCOGENE PVT-1 |
| 9p12 | BAG1 | BCL2-ASSOCIATED ATHANOGENE-1 |
| 9p21 | CDKN2A | CYCLIN-DEPENDENT KINASE INHIBITOR 2A, , p16(INK4), p16(INK4A), MULTIPLE TUMOR SUPPRESSOR 1 MTS1 |
| 9p21 | CDKN2B | CYCLIN-DEPENDENT KINASE INHIBITOR 2B, MULTIPLE TUMOR SUPPRESSOR2, MTS2 p15(INK4B), TP15 |
| 9p21 | TEK | TYROSINE KINASE, ENDOTHELIAL, TEK, PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE2 |
| 9p22.3-q31 | XP1 | XERODERMA PIGMENTOSUM I |
| 9p24 | OVC | ONCOGENE OVC |
| 9q21.3-q22.1 | GAS1 | GROWTH ARREST-SPECIFIC 1 |
| 9q22 | CKS2 | CDC2-ASSOCIATED PROTEIN CKS2 |
| 9q33-q34 | TGFBR1 | TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE I |
| 9q34.1 | ABL1 | ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1, ABL1 |
| 9q34.1 | CAN | CAIN GENE |
| 9q34 | ABO | ABO BLOOD GROUP |
| 9q34 | SET | SET GENE |
| 9q34 | VAV2 | VAV2 ONCOGENE |
| 10 | GDF10 | GROWTH/DIFFERENTIATION FACTOR 10; BONE MORPHOGENETIC PROTEIN 3B; BMP3B |
| 10p13 | BMI1 | LEUKEMIA VIRAL BMI-1 ONCOGENE, MOUSE, HOMOLOG OF |
| 10p15-p14 | IL2RA | INTERLEUKIN 2 RECEPTOR, ALPHA; IL-2 RECEPTOR; IL2R IL2R, ALPHA CHAIN T-CELL GROWTH FACTOR RECEPTOR; TCGFR TAC ANTIGEN; CD25 |
| 10p15-p14 | COEPB | CORE PROMOTER ELEMENT-BINDING PROTEIN |
| 10pter-q11 | PAC1 | PROSTATE ADENOCARCINOA 1 |
| 10q11-q12 | PACT | PAPILLARY THYROID CARCINOMA, PTC, TPC ONCOGENE |
| 10q11.2 | MEN2 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE II |
| 10q11.2 | RET | RET PROTO-ONCOGENE |
| 10q21.1 | CDC2 | CELL DIVISION CYCLE 2, G1 TO S AND G2 TO M |
| 10q21 | PTC1 | PTC1 CHIMERIC ONCOGENE; H4 GENE |
| 10q22.3-q24.1 | PJI | POLYPOSIS, JUVENILE INTESTINAL |
| 10q23.3 | PTEN | PHOSPHATE AND TENSIN HOMOLOG |
| 10q24 | HOX11 | HOMEO BOX 11 |
| 10q24 | NFKB2 | NUCLEAR FACTOR KAPPA-B, SUBUNIT 2 |
| 10q25-26 | FGF8 | FIBROBLAST GROWTH FACTOR-8, FGF8 |
| 10q25.3-q26.1 | DMBT1 | DELETED IN MALIGNANT BRAIN TUMORS 1 |
| 10q25 | MXI1 | MAX INTERACTING PROTEIN 1 |
| 10q25 | PRCA1 | PROSTATE CANCER |
| 10q26 | DEC | DELETED IN ENDOMETRIAL CARCINOMA |
| 10q26 | FGFR2 | FIBROBLAST GROWTH FACTOR RECEPTOR 2, BEK |
| 11p11.2 | KAI1 | KANGAI 1, SUPRESSOR OF TUMORIGENICITY-6; ST-6 |
| 11p11.2 | NEGF2 | NEURITE GROWTH-PROMOTING FACTOR-2, MIDKINE MDK |
| 11p12-p11.22 | SPI1 | SPLEEN FOCUS FORMING VIRUS PROVIRAL INTEGRATION ONCOGENE SPI1 |
| 11p13 | WT1 | WILMS TUMOR |
| 11p14-p13 | HCC | HEPATOCELLULAR CANCER, LIVER CANCER, HVBS1, HBVS1 |
| 11p15.1-p14 | GTF2H1 | GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 1; GTF2H, 62-KD SUBUNIT |
| 11p15.2-p15.1 | CALCA | CALCITONIN/CALCITONIN-RELATED POLYPEPTIDE, ALPHA |
| 11p15.2-p15.1 | TSG101 | TUMOR SUSCEPTIBILITY GENE 101 |
| 11p15.3-p15.1 | PTH | PARATHYROID HORMONE; PARATHYRIN; PARATHORMONE |
| 11p15.5-p15.4 | ARHG | RAS HOMOLOG GENE G |
| 11p15.5 | BWSCR1A | BECKWITH-WIEDEMANN SYNDROME CHROMOSOME REGION 1, CANIDATE A |
| 11p15.5 | CDKN1C | CYCLIN DEPENDENT KINASE INHIBITOR 1C |
| 11p15.5 | HRAS | V-HA-RAS HARVEY RAT SARCOMA VIRAL ONCOGENE HOMOLOG |
| 11p15.5 | IGF2 | INSULINLIKE GROWTH FACTOR II, IGF2 SOMATOMEDIN A |
| 11p15 | RBTN1 | T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, RHOMBOTIN-1, RHOMBOSINE RHOM1 T-CELL TRANSLOCATION GENE-1 TTG1 |
| 11pter-p13 | CD44 | CD44 ANTIGEN |
| 11q12-q13 | RELA | V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG,A |
| 11q12 | LTBP3 | LATENT TRANSFORMING GROWTH FACTOR-BETA BINDING PROTEIN 3; LTBP2 |
| 11q13.3 | BCL1 | |
| 11q13.5 | THRSP | THYROID HORMONE-RESPONSE POT14, RAT, HOMOLOG OF |
| 11q13 | CCND1 | CYCLIN D1, BCL1, B CELL LEUKEMIA 1, PRAD 1 |
| 11q13 | EMS1 | ONCOGENE EMS1 |
| 11q13 | FGF3 | FIBROBLAST GROWTH FACTOR 3, INT2 ONCOGENE |
| 11q13 | FGF4 | FIBROBLAST GROWTH FACTOR 4, HSTF1 ONCOGENE, HST |
| 11q13 | FOSL1 | FOS-LIKE ANTIGEN 1, FOSL1, FOS-RELATED ANTIGEN 1, FRA1 |
| 11q13 | MEN1 | MULTIPLE ENDOCRINE NEOPLASIA |
| 11q13 | PPP1A | PROTEIN PHOSPHATASE 1, ALPHA SUBUNIT; PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP1CA |
| 11q13 | SEA | S13 AVIAN ERYTHROBLASTOSIS ONCOGENE HOMOLOG |
| 11q13 | ST3 | SUPPRESSOR OF TUMORGENICITY-3; CCTS; CERVICAL CARCINOMA |
| 11q22.3 | AT | ATAXIA-TELANGIECTASIA; LOUIS-BAR SYNDROME |
| 11q23.3 | CBL | CAS-BR-M (MURINE) ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE |
| 11q23.3 | DDX6 | DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 6 |
| 11q23.3 | ETS1 | V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E2 ONCOGENE HOMOLOG 1 |
| 11q23 | BRC | BREAST CANCER, 11,22 TRANSLOCATION ASSOCIATED |
| 11q24 | FLI1 | VIRAL INTEGRATION REGION HUMAN HOMOLOG OF, FLI1, EWING SARCOMA BREAKPOINT REGION 2, EWSR2 |
| 11q3.3 | CLL | LEUKEMIA, CHRONIC LYMPHATIC |
| 12 | CCNT1 | CYCLIN T1; CYCLIN T; CYCLIN C-RELATED PROTEIN; CDK9-ASSOCIATED C-TYPE CYCLIN |
| 12 | IGFBP6 | INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 6; IBP6 |
| 12p11.2 | KRAG | KIRSTEN-RAS ASSOCIATED GENE |
| 12p11 | RBBP2 | RETINOBLASTOMA BINDING PROTEIN |
| 12p12.1-p11.2 | PTHLH | PARATHYROID HORMONE-LIKE HORMONE |
| 12p12.1 | KRAS2 | V-KI-RAS2 KIRSTEN RAT SARCOMA 2 V. ONCOGENE HOMOLOG |
| 12p12 | SKP1B | S-PHASE KINASE-ASSOCIATED PROTEIN 1B, CDK2/CYCLIN A-ASSOCIATED PROTEIN p19B |
| 12p13-q12.2 | RAD52 | YEAST, HUMANHOMOLOG OF, RAD52 |
| 12p13.2 | TNFR1 | TUMOR NECROSIS FACTOR RECEPTOR 1 |
| 12p13 | CCND2 | CYCLIN D2 |
| 12p13 | CDKN1B | CYCLIN DEPENDENT KINASE INHIBITOR 1B |
| 12p13 | ETV6 | ETS VARIANT GENE 6 |
| 12p13 | FGF6 | FIBROBLAST GROWTH FACTOR-6 |
| 12p13 | LTBR | LYMPHOTOXIN B RECEPTOR, LYMPHOTOXIN-BETA RECEPTOR TUMOR NECROSIS FACTOR C RECEPTOR TNFCR |
| 12p13 | RBTN3 | RHOMBOTIN-3, RHOM3, RHOMBOTIN-LIKE-2 RBTNL2 |
| 12q12 | INT1 | WNT1, WINGLESS-TYPE MMTV INTEGRATION SITE-1 |
| 12q13.2-13.3 | GLI2 | GLIOMA ASSOCIATED ONCOGENE |
| 12q13.2-q13.3 | GLI | GLIOMA-ASSOCIATED ONCOGENE HOMOLOG |
| 12q13 | CDK2 | CELL DIVISION KINASE-2 |
| 12q13 | ERBB3 | V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG3 |
| 12q13 | HPV18I2 | PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE-2 |
| 12q14.3 | MDM2 | MOUSE DOUBLE MINUTE 2 |
| 12q14 | CDK4 | CYCLIN-DEPENDENT KINASE 4 |
| 12q14 | RAP1B | RAS-RELATED PROTEIN RAP1B |
| 12q22-q24.1 | IGF1 | INSULINLIKE GROWTH FACTOR 1, IGF1, IGF-I SOMATOMEDIN C |
| 12q22 | GCT | GERM CELL TUMOR; TESTICULAR TUMORS |
| 12q22 | SCF | STEM CELL FACTOR; MAST CELL GROWTH FACTOR; MGF; HUMAN HOMOLOG OF STEEL; STEEL FACTOR; SF |
| 12q23-q24 | EPS8 | EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE-8 |
| 12q23 | ELK3 | ELK3, ETS-DOMAIN PROTEIN |
| 12q24.31 | DOC1 | DELETED IN ORAL CANCER 1 |
| 13 | BRCD1 | BREAST CANCER, DUCTAL, 1 |
| 13q11-q12 | FGF9 | FIBROBLAST GROWTH FACTOR-9 |
| 13q12.3 | BRCA2 | BREAST CANCER 2, EARLY-ONSET |
| 13q12 | FLT1 | FMS-RELATED TYROSINE KINASE-1 |
| 13q14.1 | RB1 | RETINOBLASTOMA |
| 13q34 | GAS6 | GROWTH ARREST-SPECIFIC 6; AXL RECEPTOR TYROSINE KINASE LIGAND; AXLLG AXL STIMULATORY FACTOR; AXSF |
| 13q34 | FGF14 | FIBROBLAST GROWTH FACTOR 14; FHF4 |
| 13q34 | RAP2A | RAS-RELATED PROTEIN 2A, RAP2 KREV |
| 14q11.2-q12 | BCL2L2 | BCL2-LIKE 2 |
| 14q11.2 | TCRA | T-CELL ANTIGEN RECEPTOR, ALPHA SUBUNIT |
| 14q22 | CDKN3 | CYCLIN DEPENDENT KINASE INHIBITOR 3 |
| 14q23 | MAX | MAX PROTEIN, MYC ASSOCIATED FACTOR X |
| 14q23 | MNAT1 | MENAGE A TROIS 1 |
| 14q24-q31 | PGF | PLACENTAL GROWTH FACTOR |
| 14q24.1; | FOS | V-FOS FBJ MURINE OSTEOSARCOMA V. ONCOGENE HOMOLOG /A |
| 14q24 | TGFB3 | TRANSFORMING GROWTH FACTOR, BETA-3 |
| 14q31 | OGR1 | G PROTEIN-COUPLED RECEPTOR, OVARIAN CANCER, 1 |
| 14q32.1 | PI | PROTEASE INHIBITOR 1 |
| 14q32.1 | TCL1 | T-CELL LYMPHOMA OR LEUKEMIA |
| 14q32.2 | AKT1 | V-AKT MURINE THYMOMA ONCOGENE-1 |
| 14q32.33 | IGHG1 | IgG HEAVY CHAIN LOCUS; IMMUNOGLOBULIN Gm 1 |
| 14q32.3 | ELK2 | ELK2, MEMBER OF ETS ONCOGENE FAMILY |
| 14q32 | CHGA | CHROMOGRANIN A; SECRETORY PROTEIN I, PSP |
| 14q32 | IFI27 | INTERFERON, ALPHA-INDUCIBLE PROTEIN 27 |
| 14q | RCC2 | RENAL CELL CARCINOMA 2 |
| 15 | CDC2L2 | CELL DIVISION CYCLE 2-LIKE 2 |
| 15q13-q22 | FGF7 | KERATINOCYTE GROWTH FACTOR, KGF, FIBROBLAST GROWTH FACTOR-7 |
| 15q15-q21.1 | FGF7 | FIBROBLAST GROWTH FACTOR 7; KERATINOCYTE GROWTH FACTOR; KGF |
| 15q22.3-q23 | PHAP1 | PUTATIVE HUMAN HLA CLASS II ASSOCIATED PROTEIN |
| 15q24.3 | BCL2A1 | BCL2-RELATED PROTEIN A1 |
| 15q24 | CHRNB4 | CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPIDE 4 |
| 15q25-q26 | IGF1R | INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR, IGF1R |
| 15q26.1 | BLM | BLOOM SYNDROME |
| 15q26.1 | FES | FELINE SARCOMA ONCOGENE HOMOLOG |
| 16p11.2-p12 | RBBP6 | RETINOBLASTOMA BINDING |
| 16p13.3 | CCNF | CYCLIN F |
| 16p13.3 | TSC2 | TUBEROUS SCLEROSIS 2 |
| 16q12-q13 | EPITHELIOMA, HEREDITARY MULTIPLE BENIGN CYSTIC; CDMT; EAC; CYLD1; TURBAN TUMORS; CYLINDROMAS, DERMAL ECCRINE | |
| 16q12.2 | RBL2 | RETINOBLASTOMA LIKE PROTEIN 2 |
| 16q22-q23 | MAF | V-MAF MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE, AVIAN, HOMOLOG OF |
| 16q22.1 | CDH1 | CADHERIN 1 |
| 16q22.1 | E2F4 | TRANSCRIPTION FACTOR 4, E2F4 |
| 16q22.1 | HPR | HAPTOGLOBIN-RELATED PROTEIN GENE |
| 16q22 | FRA16A | FRAGILE SITE 16q22 |
| 16q24.3 | FACA | FANCONI ANEMIA, COMPLEMENTATION GROUP A |
| 16q24 | CDH13 | CADHERIN 13 |
| 16q | WT3 | WILMS TUMOR, TYPE III |
| 17p11.2 | FLI | FLIGHTLESS-I, DROSOPHILA, HUMAN HOMOLOG OF, FLI |
| 17p13.1 | CRC | COLORECTAL CANCER, LYNCH CANCER FAMILY I |
| 17p13.1 | LOG12 | 12-@LIPOXYGENASE |
| 17p13.1 | P53 | TUMOR PROTEIN P53 |
| 17p13.3 | ABR | ACTIVE BCR-RELATED GENE |
| 17p13.3 | BCPR | BREAST CANCER-RELATED REGULATOR OF TP53 |
| 17p13.3 | CRK | V-CRK AVIAN SARCOMA VIRUS CT10 ONCOGENE HOMOLOG |
| 17q11-q12 | TRAF4 | TNF RECEPTOR-ASSOCIATED FACTOR 4 |
| 17q11-qter | ITGB4 | INTEGRIN, BETA-4 |
| 17q11.2-q12 | SCYA7 | SMALL INDUCIBLE CYTOKINE A7 |
| 17q11.2 | ERBA1 | THRA1 |
| 17q11.2 | ERBA | TRANSFORMATION GENE: ONCOGENE ERBA, ERBA-ALPHA AVIAN ERYTHROBLASTIC LEUKEMIA VIRUS THYROID HORMONE RECEPTOR, ALPHA THRA |
| 17q11.2 | NF1 | NEUROFIBROMATOSIS, TYPE I |
| 17q12-21 | ERBB2 | HER2, NEU |
| 17q12-q23.2 | CDC27 | CELL DIVISION CYCLE 27 |
| 17q12 | RARA | RETINOIC ACID RECEPTOR, ALPHA |
| 17q21-q22 | NGFR | NERVE GROWTH FACTOR RECEPTOR |
| 17q21-q22 | TOP2A | TOPOISOMERASE (DNA) II, ALPHA |
| 17q21.1 | M17S2 | MEMBRANE COMPONENT, CHROMOSOME 17, SURFACE MARKER 2 |
| 17q21.3 | NME3 | NON-METASTATIC CELLS 1, PROTEIN EXPRESSED IN |
| 17q21 | BRCA1 | BREAST CANCER, TYPE 1 |
| 17q21 | ETV4 | ETS VARIANT GENE 4, ETS TRANSLOCATION VARIANT 4, E1A ENHANCER BINDING PROTEIN E1AF |
| 17q21 | FGF11 | FIBROBLAST GROWTH FACTOR 11; FHF3 |
| 17q21 | INT4 | ONCOGENE INT4, WINGLESS-TYPE MMTV INTEGRATION SITE-3 WNT3 |
| 17q21 | PHB | PROHIBITIN |
| 17q22-q23 | TNFAIP1 | TUMOR NECROSIS FACTOR, ALPHA-INDUCED PROTEIN 1, ENDOTHELIAL |
| 17q22 | BCL5 | LEUKEMIA/LYMPHOMA, CHRONIC B-CELL, 5 |
| 17q24-q25 | GRB2 | GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2 |
| 17q24 | SSTR2 | SOMATOSTATIN RECEPTOR 2 |
| 17q24 | TOC | TYLOSIS WITH ESOPHAGEAL CANCER |
| 17q25.2-25.3 | TK1 | THYMIDINE KINASE, SOLUBLE |
| 17q25 | LGALS3BP | LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3 BINDING PROTEIN |
| 17q25 | MAFG | V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN G |
| 17q25 | TIMP2 | TISSUE INHIBITOR OF METALLOPROTEINASE-2, TIMP2 |
| 18p11.2 | ACTHR | ADRENAL UNRESPONSIVENESS TO ACTH |
| 18p11.3 | YES1 | YAMUGUCHII SARCOMA ONCOGENE |
| 18q11-q12 | LCFS2 | LYNCH CANCER FAMILY SYNDROME II, CANCER FAMILY SYNDROME |
| 18q21.1 | DPC4 | MADH4, MOTHERS AGAINST DECAPENTAPLEGIC (DROSOPHILA)HOMOLOG 4, SMAD4 DELETED IN PANCREATIC CARCINOMA 4 |
| 18q21.3 | BCL2 | LEUKEMIA, CHRONIC LYMPHATIC, TYPE 2 |
| 18q21.3 | DCC | DELETED IN COLORECTAL CARCINOMA |
| 18q21.3 | FVT1 | FOLLICULAR-VARIAN-TRANSLOCATION GENE |
| 18q21.3 | PI5 | PROTEASE INHIBITOR 5 |
| 18q21.3 | SCCA1 | SQUAMOUS CELL CARCINOMA ANTIGEN 1 |
| 18q21.3 | SCCA2 | SQUAMOUS CELL CARCINOMA ANTIGEN 2 |
| 18q21 | GRP | GASTRIN-RELEASING POLYPEPTIDE |
| 18q21 | MADH2 | MOTHERS AGAINST DECAPENTAPLEGIC (DROSOPHILA) HOMOLOG2 SMAD2 MAD (DROSOPHILA) HOMOLOG JV18-1 MADR2 |
| 18q | TGFBRE | TRANSFORMING GROWTH FACTOR BETA, RESISTANCE TO, TGFR TRANSFORMING GROWTH FACTOR, BETA 1 RESPONSE ELEMENT |
| 19 | ERBAL2 | V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG-LIKE2, ERBA-RELATED GENE-2 EAR2 |
| 19 | HKR1 | GLI-KRUPPEL FAMILY MEMBER HKR1 |
| 19 | HKR2 | GLI-KRUPPEL FAMILY MEMBER HKR2 |
| 19 | RRAS | RELATED RAS VIRAL (R-RAS) ONCOGENE HOMOLOG |
| 19p13.1-p12 | JUND | ONCOGENE JUN-D |
| 19p13.2-cen | MEL | ONCOGENE MEL |
| 19p13.2-q13.3 | LPSA | ONCOGENE LIPOSARCOMA |
| 19p13.2 | JUNB | JUNB ONCOGENE |
| 19p13.2 | RAD23A | HUMAN HOMOLOG OF YEAST RAD23, A, HHR23A |
| 19p13.3-p13.2 | VAV1 | VAV1 ONCOGENE |
| 19p13.3 | CDC34 | CELL DIVISION CYCLE 34 |
| 19p13.3 | MATK | MEGAKARYOCYTE-ASSOCIATED TYROSINE KINASE |
| 19p13.3 | PJS | PEUTZ-JEGHERS SYNDROME |
| 19p13.3 | STK11 | SERINE/THREONINE PROTEIN KINASE 11 |
| 19p13 | CDKN2D | CYCLIN-DEPENDENT KINASE INHIBITOR 2D, INK4D |
| 19q12-q13 | CCNE | CYCLIN E |
| 19q13.1-q13.2 | AXL | AXL RECEPTOR TYROSINE KINASE |
| 19q13.1-q13.3 | TGFB1 | TRANSFORMING GROWTH FACTOR, BETA 1, TGFB1, TGF-BETA |
| 19q13.1 | AKT2 | V-AKT MURINE THYMOMA ONCOGENE-2 |
| 19q13.1 | CEBPA | CCAAT/ENHANCER BINDING PROTEIN (C/EBP), ALPHA; C/EBP-ALPHA; CEBP |
| 19q13.2 | CEA | CARCINOEMBRYONIC ANTIGEN |
| 19q13.33 | PRSSL1 | PROTEASE, SERINE-LIKE, 1 |
| 19q13.3 | BAX | BAX GENE |
| 19q13.3 | FOSB | V-FOS FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG B |
| 19q13.3 | PRSS9 | PROTEASE, SERINE, 9 |
| 19Q13.4 | PTPRH | PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR TYPE, H |
| 19q13 | BCL3 | B-CELL LEUKEMIA/LYMPHOMA-3, BCL3 |
| 20p12 | PCNA | PROLIFERATING CELL NUCLEAR ANTIGEN |
| 20p13 | CDC25B | CELL DIVISION CYCLE 25B |
| 20q11.2 | GHRF | GROWTH HORMONE-RELEASING FACTOR; SOMATOCRININ; GROWTH HORMONE-RELEASING HORMONE;GHRH |
| 20q11.2 | RBL1 | RETINOBLASTOMA-LIKE 1, PROTEIN p107 |
| 20q11 | E2F1 | E2F TRANSCRIPTION FACTOR 1 |
| 20q12-q13.1 | TOP1 | TOPOISOMERASE (DNA) I |
| 20q12 | AIB1 | AMPLIFIED IN BREAST CANCER-1 |
| 20q12 | SRC | V-SRC AVIAN SARCOMA SCHMIDT-RUPPIN A-2 V. ONCOGENE |
| 20q13.1 | MYBL2 | V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG-LIKE 2 |
| 20q13 | CAS | CELLULAR APOPTOSIS SUSCEPTIBILITY |
| 20q | BCLX | BCL2-RELATED GENE, BCLX |
| 21q22.3 | ERG | V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE RELATED |
| 21q22.3 | ETS2 | V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E2 ONCOGENE HOMOLOG 2 |
| 21q22.3 | TFF1 | TREFOIL FACTOR 1, BREAST CANCER ESTOGEN-INDUCIBLE SEQUENCE; BCEI |
| 22 | BCR | |
| 22q11.21 | BCRL2 | BREAKPOINT CLUSTER REGION-LIKE 2 |
| 22q11.21 | BCRL3 | BREAKPOINT CLUSTER REGION-LIKE 3 |
| 22q11.21 | BCRL4 | BREAKPOINT CLUSTER REGION-LIKE 4 |
| 22q11.21 | CML | LEUKEMIA, CHRONIC MYELOID |
| 22q11 | CRKL | V-CRK AVIAN SARCOMA VIRUS CT10 ONCOGENE HOMOLOG-LIKE |
| 22q12.1-q13.2 | TIMP3 | TISSUE INHIBITOR OF METALLOPROTEINASE-3 |
| 22q12.2 | NF2 | NEUROFIBROMATOSIS, TYPE II |
| 22q12.3 | PDGFB | PLATELET DERIVED GROWTH FACOR BETA, SIS |
| 22q13.1 | CYP2D | CYTOCHROME P450, SUBFAMILY IID |
| 22q13 | PD-ECGF | ENDOTHELIAL CELL GROWTH FACTOR, PLATELET-DERIVED; ECGF1 |
| Xp11.22 | TFE3 | TRANSCRIPTION FACTOR FOR IMMUNOGLOBULIN HEAVY-CHAIN ENHANCER-3 |
| Xp11.2 | ELK1 | ELK1, MEMBER OF ETS ONCOGENE FAMILY |
| Xp11.2 | RCCPX | RENAL CELL CARCINOMA, PAPILLARY, X-LINKED |
| Xp11.3-p11.23 | TIMP | TISSUE INHIBITOR OF METALLOPROTEINASE-1, TIMP1, ERYTHROID POTENTIATING ACTIVITY EPA COLLAGENASE INHIBITOR |
| Xp11.4-p11.2 | ARAF1 | V-RAF MURINE SARCOMA 3611 VIRAL ONCOGENE HOMOLOG 1 |
| Xp11 | PCTK1 | PCTAIRE PROTEIN KINASE 1 |
| Xq11-q12 | AR | ANDROGEN RECEPTOR; DIHYDROTESTOSTERONE RECEPTOR |
| Xq21-q22 | TDGF2 | TERATOCARCINOMA-DERIVED GROWTH FACTOR-2, TDGF2, CRIPTO-RELATED SEQUENCE, X-LINKED |
| Xq22-q28 | MYCL2 | MYCL-RELATED PROCESSED GENE |
| Xq26 | FGF13 | FIBROBLAST GROWTH FACTOR 13; FHF2 |
| Xq27 | MCF2 | MCF.2 CELL LINE DERIVED TRANSFORMING SEQUENCE |
| Xq28 | L1CAM | L1 CELL ADHESION MOLECULE, MIC5 NEURAL CELL ADHESION MOLECULE L1 CAML1 |